Armata Pharmaceuticals, Inc.
ARMP
$1.42
$0.06815.04%
AMEX
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | 113.10% | 82.41% | 353.34% | -72.68% | -92.43% |
| Total Depreciation and Amortization | 29.69% | 41.63% | 38.16% | 37.83% | 19.59% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -211.06% | -113.04% | -225.84% | 293.43% | 2,836.43% |
| Change in Net Operating Assets | 113.46% | -1,116.30% | 77.71% | 76.91% | 3,194.44% |
| Cash from Operations | 2.21% | 8.51% | 15.61% | 39.76% | 22.69% |
| Capital Expenditure | 103.21% | 90.32% | -515.32% | 87.56% | -627.47% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 103.22% | 90.32% | -515.32% | 87.56% | -625.27% |
| Total Debt Issued | -- | -100.00% | 100.00% | 17.89% | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -100.00% | -- | -- | -- |
| Repurchase of Common Stock | 100.00% | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 100.00% | -100.25% | 123.91% | 18.03% | 91.40% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 25.51% | -179.82% | 9.45% | 140.63% | -0.09% |